The table below shows ENANTA PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$65.32M
$67.64M
$79.20M
$86.16M
$97.07M
$122.47M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$106.74M
$131.48M
$163.52M
$164.52M
$174.11M
$136.76M
SG&A
ENTA annual revenue (10-K history)
ENANTA PHARMACEUTICALS INC reported annual revenue of $65.32M for fiscal year 2025. That is down 3.4% from $67.64M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $88.27M (FY 2016) to $65.32M. Figures come from the company's audited annual reports as filed with the SEC.